S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Helius Medical Technologies (HSDT) Competitors

$5.97
+0.17 (+2.93%)
(As of 02/23/2024 ET)

HSDT vs. CHFS, BSGM, NUWE, TIVC, NDRA, NAVB, PEAR, SNPX, PALI, and GOVX

Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Nuwellis (CHFS), BioSig Technologies (BSGM), Nuwellis (NUWE), Tivic Health Systems (TIVC), ENDRA Life Sciences (NDRA), Navidea Biopharmaceuticals (NAVB), Pear Therapeutics (PEAR), Synaptogenix (SNPX), Palisade Bio (PALI), and GeoVax Labs (GOVX). These companies are all part of the "medical" sector.

Helius Medical Technologies vs.

Helius Medical Technologies (NASDAQ:HSDT) and Nuwellis (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings, valuation and community ranking.

Helius Medical Technologies has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

Helius Medical Technologies has higher earnings, but lower revenue than Nuwellis. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical Technologies$790K5.16-$14.07M-$21.49-0.27
Nuwellis$5.51M0.66-$18.11M-$279.280.00

In the previous week, Helius Medical Technologies had 2 more articles in the media than Nuwellis. MarketBeat recorded 2 mentions for Helius Medical Technologies and 0 mentions for Nuwellis. Helius Medical Technologies' average media sentiment score of 0.00 equaled Nuwellis'average media sentiment score.

Company Overall Sentiment
Helius Medical Technologies Neutral
Nuwellis Neutral

Helius Medical Technologies presently has a consensus price target of $85.00, indicating a potential upside of 1,370.59%. Given Helius Medical Technologies' higher probable upside, equities research analysts clearly believe Helius Medical Technologies is more favorable than Nuwellis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helius Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nuwellis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

65.1% of Nuwellis shares are owned by institutional investors. 7.3% of Helius Medical Technologies shares are owned by insiders. Comparatively, 0.6% of Nuwellis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nuwellis received 305 more outperform votes than Helius Medical Technologies when rated by MarketBeat users. Likewise, 69.53% of users gave Nuwellis an outperform vote while only 55.88% of users gave Helius Medical Technologies an outperform vote.

CompanyUnderperformOutperform
Helius Medical TechnologiesOutperform Votes
19
55.88%
Underperform Votes
15
44.12%
NuwellisOutperform Votes
324
69.53%
Underperform Votes
142
30.47%

Nuwellis has a net margin of -254.26% compared to Helius Medical Technologies' net margin of -1,602.40%. Nuwellis' return on equity of -173.61% beat Helius Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Helius Medical Technologies-1,602.40% -232.74% -100.23%
Nuwellis -254.26%-173.61%-131.01%

Summary

Nuwellis beats Helius Medical Technologies on 8 of the 15 factors compared between the two stocks.


Get Helius Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSDT vs. The Competition

MetricHelius Medical TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$4.08M$3.32B$5.03B$7.52B
Dividend YieldN/A1.66%2.92%3.86%
P/E Ratio-0.2712.19101.2616.11
Price / Sales5.1675.563,103.9555.29
Price / CashN/A14.1988.3852.42
Price / Book0.404.074.364.63
Net Income-$14.07M$88.57M$112.59M$207.21M
7 Day Performance-3.37%3.23%0.86%-0.98%
1 Month Performance-17.53%3.69%6.85%3.29%
1 Year Performance-58.85%51.06%8.77%3.69%

Helius Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHFS
Nuwellis
0 of 5 stars
$0.70
+16.6%
N/A-91.4%$4.23M$5.51M-0.0166Gap Up
High Trading Volume
BSGM
BioSig Technologies
0 of 5 stars
$0.52
-16.1%
N/A-97.6%$4.69M$290,000.00-0.1147News Coverage
Gap Up
High Trading Volume
NUWE
Nuwellis
0.7314 of 5 stars
$0.70
+16.6%
N/A-91.6%$2.29M$8.54M-0.0470Upcoming Earnings
News Coverage
High Trading Volume
TIVC
Tivic Health Systems
0 of 5 stars
$1.24
flat
N/A-94.2%$1.82M$1.23M-0.0316News Coverage
Gap Down
NDRA
ENDRA Life Sciences
2.8242 of 5 stars
$1.12
-2.6%
$9.00
+703.6%
-67.6%$12.37MN/A-0.4021Gap Down
NAVB
Navidea Biopharmaceuticals
0 of 5 stars
$0.04
flat
N/A-82.6%$4.15M$70,000.00-0.6911News Coverage
PEAR
Pear Therapeutics
0 of 5 stars
N/AN/AN/A$4.17M$12.69M-0.13300
SNPX
Synaptogenix
0 of 5 stars
$0.21
+17.1%
N/A-83.3%$4.19MN/A-0.205News Coverage
PALI
Palisade Bio
2.0714 of 5 stars
$0.44
+2.3%
$8.75
+1,888.6%
-81.9%$4.08MN/A0.0012Gap Up
GOVX
GeoVax Labs
2.8261 of 5 stars
$2.36
+0.4%
$90.00
+3,713.6%
-81.1%$4.20M$80,000.00-0.1814News Coverage

Related Companies and Tools

This page (NASDAQ:HSDT) was last updated on 2/23/2024 by MarketBeat.com Staff